CBS 2019
CBSMD教育中心
中 文

Acute Coronary Syndrom

Abstract

Recommended Article

Complete Versus Culprit-Only Revascularization in STEMI: a Contemporary Review Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial Patterns of use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers among patients with acute myocardial infarction in China from 2001 to 2011: China PEACE-Retrospective AMI Study No causal effects of plasma homocysteine levels on the risk of coronary heart disease or acute myocardial infarction: A Mendelian randomization study 1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor Cardiac Troponin Composition Characterization after Non ST-Elevation Myocardial Infarction: Relation with Culprit Artery, Ischemic Time Window, and Severity of Injury Frequency of nonsystem delays in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention and implications for door-to-balloon time reporting (from the American Heart Association Mission: Lifeline program) Pharmacotherapy in the Management of Anxiety and Pain During Acute Coronary Syndromes and the Risk of Developing Symptoms of Posttraumatic Stress Disorder

Original Researche13197, 2019 Dec 27 [Online ahead of print]

JOURNAL:Eur J Clin Invest. Article Link

Improvement of Clinical Outcome in Patients With ST-Elevation Myocardial Infarction Between 1999 And 2016 in China : The Prospective, Multicenter Registry MOODY Study

MX Chen, J Kan, JJ Zhang et al. Keywords: STEMI; clinical events; in-hospital death; PCI; trained operator

ABSTRACT


BACKGROUND - Reports showed no change of 7‐day mortality after primary percutaneous coronary intervention (PCI) for ST‐elevation myocardial infarction (STEMI) between 2001 and 2011 in China. National rolling one‐year interventional standardized training program began in September 2009. However, the improvement in clinical outcome following STEMI PCI after 2011 remains unclear.


METHODS AND RESULTS - This multicenter MOODY registry study aimed to analyze the clinical improvement after STEMI PCI. Of a total of 9265 acute MI patients registered from 24 centers, 3142 STEMIs having a first medical contact time ≤12 hours and undergoing primary PCI were assigned to the Pre Group (n=1014, between March 1999 and October 2010) or the Post Group (n=2128, between 2010 November and 2016 Ocotber). The primary endpoint was in‐hospital cardiac death. Study endpoints were also compared between trained and untrained operators and between experienced (≥ 50 primary PCIs/year) and inexperienced personnel.

In‐hospital death after PCI was 3.0% in the Pre Group, significantly higher than 1.6% in the Post Group (p=0.035). The improvements in clinical outcome after PCI between the 2016 and Pre Groups were stably sustained through one‐year follow‐up. The significant reduction for in‐hospital death was noted when primary PCI was performed by trained (1.4% vs 5.4%, p<0.001) or experienced (2.7% vs 4.8%, p=0.001) operators, compared to untrained or inexperienced operators, respectively. Inclusion of the untrained operator into the conventional risk model strongly enhanced the prediction for endpoints. Age, Killip Class 3, diabetes, trans‐radial approach, and system delay were five predictors of in‐hospital death after primary PCI.


CONCLUSION - PCI for STEMI by a trained and experienced operator was associated with significant reduction of in‐hospital death. Our results strongly warrant the need for promoting the current system response and patient education.